In this issue:
Minimally-invasive vs open radical cystectomy for bladder cancer
Risk of CVD in diabetic men with prostate cancer receiving GnRH agonists
CheckMate 9ER: Front-line nivolumab/cabozantinib superior to sunitinib for RCC
Testicular cancer survivorship is impacted by modifiable factors
Reduced scope of post-operative surveillance safe in stage 1 seminoma
Conventional vs hypofractionated radiation for high-risk prostate cancer
MFS after PSMA-PET-guided salvage radiotherapy
Reducing adjuvant chemotherapy in good-prognosis metastatic seminoma feasible
Molecular subtypes of urothelial carcinoma respond differently to chemotherapy
Neoadjuvant gemcitabine intravesical drug delivery system promising for MIBC
Please login below to download this issue (PDF)